Medtox Scientific, Inc. (MTOX) Cash Flow Statement

Click line-items for a historical chart and %

Net income
Depreciation and amortization	3.12M
Provision for losses on accounts receivable
Loss on sale of equipment	-2K
Deferred and stock-based compensation	924K
Deferred income taxes	1.47M
Accounts receivable	-5.03M
Inventories	-206K
Prepaid expenses
Other assets	-85K
Accounts payable and accrued expenses	1.63M
Net cash provided by operating activities	6.22M
Purchase of building, equipment and improvements	-3.12M
Net cash used in investing activities	-3.12M
Proceeds from line of credit	0
Payments on line of credit	0
Principal payments on long-term debt
Purchase of common stock for incentive plans
Net proceeds from the exercise of stock options
Payment of taxes from traded shares
Net cash (used in) provided by financing activities	-1.54M
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	1.55M
CASH AND CASH EQUIVALENTS AT BEGINNING OF PERIOD	5.27M
CASH AND CASH EQUIVALENTS AT END OF PERIOD	6.82M
Interest	128K
Income taxes	631K
Asset additions and related obligations in payables	587K

Entities mentioned with MTOX

View All Entities